24th Porto Cancer Meeting 2017
Liquid biopsy: bringing precision medicine closer to oncology

costa_luisLuís Costa
Lisbon University / Hospital de Santa Maria

Dr Luís Costa is Professor of Medicine at the Lisbon Medical School – University of Lisbon, Portugal and he is the head of the Clinical Translational Oncology Research Unit at IMM since 2007. Dr. Luis Costa serves also as director of Oncology Department at Hospital de Santa Maria in Lisbon since 2005. At the School of Medicine he is the Coordinator Professor of “Oncobiologia” a new teaching unit that aims to teach the understanding of clinical oncology through molecular medicine.

In 2015 Dr. Luis Costa was appointed as director of the Clinical Research Center at the Lisbon Academic Center of Medicine. In 2016, Dr. Luís Costa was elected president of the ASPIC (Associação Portuguesa para Investigação do Cancro”.

Dr. Luis Costa is the IMM Portuguese representative of the Global Cancer Genomics Consortium. Dr. Luis Costa acts also as an expert for grant reviews at the European Research Council, the Cancer Research UK, CAIBER (Spanish Clinical Research Network), and the French National Cancer Institute. Professor Costa’s clinical research, publications and scientific presentations have primarily focused on bone metastases, related to breast cancer, prostate cancer and other solid tumors. He has published various peer-reviewed papers discussing these topics. Dr. Costa is Academic Editor of Plos One and of The Journal of Bone Oncology.